Mabion S.A. (FRA:272)
1.904
-0.020 (-1.04%)
At close: Jan 30, 2026
Mabion Market Cap
Mabion has a market cap or net worth of €31.37 million as of January 30, 2026. Its market cap has decreased by -14.49% in one year.
Market Cap
31.37M
Enterprise Value
30.96M
Revenue
3.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.90
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 23.37M to 31.37M, an increase of 34.20%. That is a compound annual growth rate of 1.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 31.37M | 17.37% |
| Dec 30, 2025 | 26.72M | -20.62% |
| Dec 30, 2024 | 33.66M | -50.13% |
| Dec 29, 2023 | 67.50M | -6.93% |
| Dec 30, 2022 | 72.53M | -66.30% |
| Dec 30, 2021 | 215.22M | 246.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PEH Wertpapier AG | 46.40M |
| U.C.A. Aktiengesellschaft | 41.14M |
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 40.70M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Biomark Diagnostics | 29.64M |
| Weng Fine Art AG | 29.08M |